The Nightview Fund Q1 2026 Investor Letter

The Nightview Fund said it held 20 names and added Axon in late February after a sharp correction during the broader software selloff. The note signals disciplined capital deployment and constructive conviction in high-quality businesses at reasonable prices. Impact is limited to portfolio positioning rather than a broader market or company-specific catalyst.

Analysis

AXON looks more interesting as a flow and positioning story than as a pure fundamentals call. In a broad software de-risking tape, names with defensible growth and mission-critical end markets tend to get sold indiscriminately first, then re-rated fastest once the marginal seller is exhausted; that usually creates a short, violent dislocation rather than a multi-quarter thesis break. The key second-order effect is that high-quality secular compounders can absorb capital from crowded software adjacency trades, so the stock can outperform simply because it becomes the cleanest way to express "growth without balance-sheet risk".

The main risk is that the market may be underestimating how long multiple compression can persist if factor pressure remains dominant. In the near term, any continuation of higher real yields or risk-off flows could cap upside even if company execution remains intact, meaning the stock may need time rather than a catalyst to work. The reversal trigger is likely not a headline, but stabilization in software basket breadth and a reduction in forced selling from momentum/systematic funds over the next 2-6 weeks.

The contrarian view is that the selloff may be less about the company and more about crowded ownership plus valuation fragility. That means the opportunity is best expressed tactically: the stock can re-rate sharply if it reclaims relative strength, but chasing immediately after a sharp correction risks buying before the de-grossing finishes. A cleaner setup would be to wait for confirmation that the broader software complex has stopped making new lows, then use AXON as a quality-leader long rather than a mean-reversion punt.

Key Decisions for Investors

• Buy AXON on weakness only if it holds relative strength versus the software basket over the next 1-3 weeks; target a 10-15% rebound on de-grossing, with a tight 5-7% stop if the sector selloff resumes.
• Initiate a pair trade: long AXON / short a lower-quality software beta basket for 1-2 months to isolate quality and avoid pure factor exposure; target 300-500 bps of spread capture if software breadth stabilizes.
• If you want defined risk, buy AXON call spreads 2-3 months out and finance with a partial put sale only after momentum turns; this captures a sharp snapback while limiting damage if multiple compression continues.
• Do not chase size immediately after the correction; scale in over 2-3 tranches so you can add only if systematic selling pressure abates and the stock holds above the post-selloff lows.
• Monitor for a reversal signal in software ETFs and high-multiple growth leaders; if those fail to stabilize within 30 days, reduce AXON exposure rather than treating it as an isolated stock-specific dislocation.